Sign in

CIK 0001689375

  • Accelerated filer
  • Smaller reporting company
  • Emerging growth company

Entrada Therapeutics, Inc.

Sign in to watch
Ticker
TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813983399
Phone
+1 857-305-1825
Business address
ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
Former names
CycloPorters, Inc.
  1. 4 Shares withheld for taxes President, Research & Develop. gave up 1,760 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Financial Officer gave up 1,734 shares (to pay taxes)
  3. 4 Open-market sale Director sold 27,000 shares at $7.50 ($202,554)
  4. 4 Open-market sale 10% owner sold 27,000 shares at $7.50 ($202,554)
  5. 4 Open-market sale Director sold 125,000 shares at an average $6.93 ($866,633)
  6. 4 Open-market sale 10% owner sold 125,000 shares at an average $6.93 ($866,633)
  7. 4/A Open-market buy Director bought 50,000 shares at an average $14.63 ($731,683)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Option exercise Chief Financial Officer acquired 11,134 shares (option exercise)
  16. 4 Planned sale Chief Financial Officer sold 1,784 shares at $10.67 ($19,035)
  17. 4 Shares withheld for taxes CEO gave up 17,566 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Financial Officer gave up 4,929 shares (to pay taxes)
  19. 4 Shares withheld for taxes President & COO gave up 5,144 shares (to pay taxes)
  20. 4 Shares withheld for taxes President, Research & Develop. gave up 6,138 shares (to pay taxes)

Page 3 of 13 · 242 filings